Frontlight ResearchEarly access
Trial site
First Affiliated Hospital of Zhejiang University Schlool of Medicine
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Pancreatic cancer6 trials
- Phase
- Phase 1/23 trials
- Phase 23 trials
- Status
- Not yet recruiting5 trials
- Recruiting1 trial
- Lead sponsor
- Zhejiang University5 trials
- First Affiliated Hospital of Zhejiang University1 trial
Running trials
Recruiting
HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation
Recruiting
IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer
Not yet recruiting
Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer.
Not yet recruiting
Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer.
Recruiting
Recruiting
Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Pancreatic cancer6 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026